Skip to main content
Fig. 2 | BMC Surgery

Fig. 2

From: Endoscopic main duct stenting in refractory postoperative pancreatic fistula after distal pancreatectomy – a friend or a foe?

Fig. 2

Laboratory dynamics for patients not developing post operative pancreatic fistula (POPF) and for patients with POPF managed with endoscopic treatment (ET) or not. The dotted line in A and B represents the institutional upper normal limit. The dynamics comprise post-operative day (POD) 1–3 for figures A, C and E, as well as maximum values first post-operative week (POW1), pre- and post-ET for figures B, D and F. (A) Serum amylase activity POD1-3 (B) Max values for serum amylase activity POW1, pre-ET and post-ET. (C) Drain amylase activity POD1-3 (D) Max values for drain amylase activity POW1, pre-ET and post-ET. Note the change in the y-axis. (E) C-reactive Protein POD1-3 (F) Max values for C-reactive Protein POW1, pre-ET and post-ET.

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us